youtube_live
Zarada za Q3 2026 • objavljeno • EPS je premašen +8,62% • Prihod je premašen +2,31%
Pogledajte rezultatechevron_right
EW:NYSE
Edwards Lifesciences Corp
105,16 USD
arrow_upward
+2,96%(+3,02) 1D
9. stu, 15:48:39 GMT -5 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za EW...
Otvori
102,85 USD
Najviša
105,37 USD
Najniža
102,17 USD
Trž. kap.
60,47 mlr.
Prosj. kol.
4,37 mil.
Količina
3,85 mil.
P/E omjer
59,62
52-tjed. najviša
105,37 USD
52-tjed. najniža
74,66 USD
EPS
1,76 USD
Beta
0,85
Dionice u optjecaju
575,00 mil.
Broj djelatnika
16 tis.
Otvori
102,85 USD
Najviša
105,37 USD
Najniža
102,17 USD
Trž. kap.
60,47 mlr.
Prosj. kol.
4,37 mil.
Količina
3,85 mil.
P/E omjer
59,62
52-tjed. najviša
105,37 USD
52-tjed. najniža
74,66 USD
EPS
1,76 USD
Beta
0,85
Dionice u optjecaju
575,00 mil.
Broj djelatnika
16 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Investing.com
·
prije 5 sati
Edwards Lifesciences stock rating maintained at Buy by TD Cowen
Investing.com
·
prije 12 sati
Edwards Lifesciences CVP Daveen Chopra sells $2.9M in stock
Yahoo Finance
·
prije 2 dana
Edwards Lifesciences Q3 Earnings Call Highlights
Profil
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Edwards Lifesciences Corp – informacije
Glavni izvršni direktor-
Zaposlenici16 tis.
Osnovano1958
SjedišteIrvine, Kalifornija, Sjedinjene Američke Države
SektorHealth Care
Djelatnost-
Web-lokacijaedwards.com